Sinotherapeutics Inc. (SHA:688247)

Sinotherapeutics Revenue

Sinotherapeutics had revenue of 91.42M CNY in the quarter ending September 30, 2026, a decrease of -18.27%. This brings the company's total for the last twelve months to 397.68M, down -17.23% year-over-year. In the year 2025, Sinotherapeutics had annual revenue of 446.57M, down -12.71%. That makes Sinotherapeutics the 26,652nd largest company in the world by revenue and 4,668th in China.

• Revenue (ttm): 397.68M
• Revenue Growth: -17.23%
• P/S Ratio: 9.28
• Revenue / Employee: 1.25M
• Employees: 319
• Market Cap: 3.57B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 316.39M 70.9%
• Overseas 129.66M 29.1%

Fiscal year ended Dec 31, 2025 See the full Sinotherapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	446.57M	-65.05M	-12.71%
Dec 31, 2024	511.62M	211.75M	70.61%
Dec 31, 2023	299.87M	52.31M	21.13%
Dec 31, 2022	247.56M	-67.91M	-21.53%
Dec 31, 2021	315.47M	-3.69M	-1.16%

Data Source: S&P Global Market Intelligence Last updated: Oct 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error